BioSpace News Archive

BioSig Technologies, Inc. announced that it will be presenting at the Q2 2018 Emerging Medical Technologies Spotlight virtual event, hosted by Life Science Intelligence. Streaming will begin at 13:00 ET, 10:00 PT, on Friday, June 29.

Data presented today at the American Headache Society (AHS) Annual Scientific Meeting demonstrate 43% of patients receiving 300 mg of eptinezumab achieved a 75% or greater reduction of monthly migraine days

Marina Biotech, Inc. announced that each of Uli Hacksell, Ph.D. and Robert C. Moscato, Jr. has been appointed to serve as a member of its Board of Directors, with Dr. Hacksell also being appointed to serve as Chairman of the Board. Dr. Hacksell has agreed to devote half of his business time to Marina. Mr. Moscato currently serves as the Chief Executive Officer of the Company.

Bioanalytical Systems, Inc. and Seventh Wave Laboratories, LLC, today announced that they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and greater scientific expertise to clients.

Fibrocell Science, Inc. announced that it has entered into definitive agreements with several institutional investors for the purchase of 1,474,080 shares of its common stock

Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has initiated coverage of Genprex Inc.

Innovative Health Solutions’ BRIDGE Device Helps Patients Withdrawal and Leave Hospital Sooner

Lexington Biosciences, Inc. wishes to provide the results of its recent Annual General Meeting.

ASLAN Pharmaceuticals announced the submission of a clinical trial authorisation application with the Singapore Health Sciences Authority (HSA) to initiate a phase 1 trial of ASLAN004.

Elite Pharmaceuticals, Inc. announced that it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for generic Percocet® (Oxycodone Hydrochloride and Acetaminophen, USP CII)